QR-koda

Cardiac Myosin Inhibitors (CMIs) and Surgical Referral in Patients with Hypertrophic Cardiomyopathy

The management of obstructive hypertrophic cardiomyopathy (HCM) has been transformed by the advent of cardiac myosin inhibitors (CMIs), such as mavacamten and aficamten. Unlike traditional pharmacotherapy, which primarily addresses symptoms, CMIs target the underlying mechanism of sarcomeric hyperco...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Benedetto Ferraresi, Antonio Nenna, Mohamad Jawabra, Diletta Corrado, Andrea Faggiano, Stefano Carugo, Carmelo Dominici, Giovanni Casali, Massimo Chello, Mario Lusini
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: MDPI AG 2026-04-01
Ráidu:Journal of Cardiovascular Development and Disease
Fáttát:
hypertrophic cardiomyopathy
cardiac myosin inhibitors
mavacamten
septal reduction therapy
surgical myectomy
Liŋkkat:https://www.mdpi.com/2308-3425/13/5/187
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid